Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease

Hsiu Ting Tsai, Pen Hua Su, Tsung Hsien Lee, Yi Torng Tee, Long Yau Lin, Shun Fa Yang, Po Hui Wang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Backgrounds: To detect the expression of plasma neutrophil gelatinase associated lipocalin (NGAL) and its complex with matrix metalloproteinase-9 (MMP-9) in patients with pelvic inflammatory disease (PID). Methods: Enzyme-linked immunosorbent assay was used to measure the levels of plasma NGAL and NGAL/MMP-9 complex. Results: The levels of plasma NGAL or NGAL/MMP-9 complex were increased in patients with PID compared with those in normal controls and decreased significantly after treatment. Pre-treatment plasma level of NGAL was significantly correlated with WBC and neutrophil counts. In patients with PID, plasma level of NGAL/MMP-9 complex was correlated with plasma level of NGAL or MMP-9 significantly. In predicting PID, the sensitivities of NGAL and NGAL/MMP-9 complex were 76.6% and 78.1%; the negative predictive values, 72.7% and 74.5%. Conclusions: Plasma NGAL and NGAL/MMP-9 complex may act as diagnostic adjuvant biomarkers for PID. In patients with PID, about 80% have plasma levels of NGAL or NGAL/MMP-9 complex level > 10.04. ng/ml or 2.33. ng/ml, respectively.

Original languageEnglish
Pages (from-to)1252-1256
Number of pages5
JournalClinica Chimica Acta
Volume412
Issue number13-14
DOIs
Publication statusPublished - Jun 11 2011
Externally publishedYes

Fingerprint

Lipocalins
Pelvic Inflammatory Disease
Gelatinases
Matrix Metalloproteinase 9
Plasmas
Lipocalin-2
Immunosorbents
Biomarkers

Keywords

  • Neutrophil gelatinase associated lipocalin
  • Neutrophil gelatinase associated lipocalin/matrix metalloproteinase-9 complex
  • Pelvic inflammatory disease

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. / Tsai, Hsiu Ting; Su, Pen Hua; Lee, Tsung Hsien; Tee, Yi Torng; Lin, Long Yau; Yang, Shun Fa; Wang, Po Hui.

In: Clinica Chimica Acta, Vol. 412, No. 13-14, 11.06.2011, p. 1252-1256.

Research output: Contribution to journalArticle

Tsai, Hsiu Ting ; Su, Pen Hua ; Lee, Tsung Hsien ; Tee, Yi Torng ; Lin, Long Yau ; Yang, Shun Fa ; Wang, Po Hui. / Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. In: Clinica Chimica Acta. 2011 ; Vol. 412, No. 13-14. pp. 1252-1256.
@article{e387c6dc0df14607abaf439e25aab505,
title = "Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease",
abstract = "Backgrounds: To detect the expression of plasma neutrophil gelatinase associated lipocalin (NGAL) and its complex with matrix metalloproteinase-9 (MMP-9) in patients with pelvic inflammatory disease (PID). Methods: Enzyme-linked immunosorbent assay was used to measure the levels of plasma NGAL and NGAL/MMP-9 complex. Results: The levels of plasma NGAL or NGAL/MMP-9 complex were increased in patients with PID compared with those in normal controls and decreased significantly after treatment. Pre-treatment plasma level of NGAL was significantly correlated with WBC and neutrophil counts. In patients with PID, plasma level of NGAL/MMP-9 complex was correlated with plasma level of NGAL or MMP-9 significantly. In predicting PID, the sensitivities of NGAL and NGAL/MMP-9 complex were 76.6{\%} and 78.1{\%}; the negative predictive values, 72.7{\%} and 74.5{\%}. Conclusions: Plasma NGAL and NGAL/MMP-9 complex may act as diagnostic adjuvant biomarkers for PID. In patients with PID, about 80{\%} have plasma levels of NGAL or NGAL/MMP-9 complex level > 10.04. ng/ml or 2.33. ng/ml, respectively.",
keywords = "Neutrophil gelatinase associated lipocalin, Neutrophil gelatinase associated lipocalin/matrix metalloproteinase-9 complex, Pelvic inflammatory disease",
author = "Tsai, {Hsiu Ting} and Su, {Pen Hua} and Lee, {Tsung Hsien} and Tee, {Yi Torng} and Lin, {Long Yau} and Yang, {Shun Fa} and Wang, {Po Hui}",
year = "2011",
month = "6",
day = "11",
doi = "10.1016/j.cca.2011.03.021",
language = "English",
volume = "412",
pages = "1252--1256",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "13-14",

}

TY - JOUR

T1 - Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease

AU - Tsai, Hsiu Ting

AU - Su, Pen Hua

AU - Lee, Tsung Hsien

AU - Tee, Yi Torng

AU - Lin, Long Yau

AU - Yang, Shun Fa

AU - Wang, Po Hui

PY - 2011/6/11

Y1 - 2011/6/11

N2 - Backgrounds: To detect the expression of plasma neutrophil gelatinase associated lipocalin (NGAL) and its complex with matrix metalloproteinase-9 (MMP-9) in patients with pelvic inflammatory disease (PID). Methods: Enzyme-linked immunosorbent assay was used to measure the levels of plasma NGAL and NGAL/MMP-9 complex. Results: The levels of plasma NGAL or NGAL/MMP-9 complex were increased in patients with PID compared with those in normal controls and decreased significantly after treatment. Pre-treatment plasma level of NGAL was significantly correlated with WBC and neutrophil counts. In patients with PID, plasma level of NGAL/MMP-9 complex was correlated with plasma level of NGAL or MMP-9 significantly. In predicting PID, the sensitivities of NGAL and NGAL/MMP-9 complex were 76.6% and 78.1%; the negative predictive values, 72.7% and 74.5%. Conclusions: Plasma NGAL and NGAL/MMP-9 complex may act as diagnostic adjuvant biomarkers for PID. In patients with PID, about 80% have plasma levels of NGAL or NGAL/MMP-9 complex level > 10.04. ng/ml or 2.33. ng/ml, respectively.

AB - Backgrounds: To detect the expression of plasma neutrophil gelatinase associated lipocalin (NGAL) and its complex with matrix metalloproteinase-9 (MMP-9) in patients with pelvic inflammatory disease (PID). Methods: Enzyme-linked immunosorbent assay was used to measure the levels of plasma NGAL and NGAL/MMP-9 complex. Results: The levels of plasma NGAL or NGAL/MMP-9 complex were increased in patients with PID compared with those in normal controls and decreased significantly after treatment. Pre-treatment plasma level of NGAL was significantly correlated with WBC and neutrophil counts. In patients with PID, plasma level of NGAL/MMP-9 complex was correlated with plasma level of NGAL or MMP-9 significantly. In predicting PID, the sensitivities of NGAL and NGAL/MMP-9 complex were 76.6% and 78.1%; the negative predictive values, 72.7% and 74.5%. Conclusions: Plasma NGAL and NGAL/MMP-9 complex may act as diagnostic adjuvant biomarkers for PID. In patients with PID, about 80% have plasma levels of NGAL or NGAL/MMP-9 complex level > 10.04. ng/ml or 2.33. ng/ml, respectively.

KW - Neutrophil gelatinase associated lipocalin

KW - Neutrophil gelatinase associated lipocalin/matrix metalloproteinase-9 complex

KW - Pelvic inflammatory disease

UR - http://www.scopus.com/inward/record.url?scp=79955457644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955457644&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2011.03.021

DO - 10.1016/j.cca.2011.03.021

M3 - Article

VL - 412

SP - 1252

EP - 1256

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 13-14

ER -